Insulin stimulates glucose transport via phosphatidylinositol 3-kinase-dependent and -independent pathways. The phosphatidylinositol 3-kinase-independent pathway involves activation of the G protein TC10. A cDNA encoding the mouse homolog of TC10 was cloned, and its gene was mapped at the distal end of chromosome 17. Additionally, a second gene was discovered with ϳ70% sequence identity to TC10. We refer to this gene as TC10␤. Both isoforms of TC10 were activated by insulin upon transfection in 3T3L1 adipocytes. Cotransfection of cells with TC10␣ or ␤ plus a dominant negative form of the c-cbl-associated protein CAP prevented the activation by insulin, implicating the CAP/Cbl pathway. Interestingly, both forms of TC10 were also localized in lipid raft fractions in transfected adipocytes. However, although overexpression of TC10␣ completely blocked glucose transport, TC10␤ only partially inhibited this process. Furthermore, TC10␣ overexpression disrupted adipocyte cortical actin, whereas TC10␤ had little if any effect. Thus, there are two isoforms of this key signaling intermediate, both of which are activated by insulin, but they may play different roles in initiating downstream effectors that influence glucose transport.
Insulin increases glucose uptake by stimulating the translocation of the GLUT4 glucose transporter isoform from intracellular storage sites to the cell surface (1) (2) (3) . Although it has been well established that the activation of phosphatidylinositol 3-kinase and the generation of phosphatidylinositol-3,4,5-trisphosphate is essential for this biological response, several lines of evidence indicate that it is not sufficient (4 -9) . Recent data suggest that the second requisite pathway might involve the insulin-stimulated tyrosine phosphorylation of Cbl (10 -12) . Cbl forms a complex with the adapter protein CAP, 1 a member of the SoHo family of proteins that contains a flotillin-binding SoHo domain in its amino terminus and three adjacent SH3 domains in its carboxyl terminus (11) (12) (13) . Once phosphorylated, the Cbl/CAP complex is recruited to lipid raft plasma membrane subdomains through the interaction of CAP with flotillin. The expression of dominant-interfering CAP mutants that lack either the SH3 or SoHo domains prevented the localization of this complex to plasma membrane microdomains and inhibited the stimulation of glucose uptake and GLUT4 translocation by insulin (13) .
Following insulin-stimulated tyrosine phosphorylation, Cbl recruits the SH2-containing adapter protein CrkII to lipid raft microdomains along with the guanine nucleotide exchange factor C3G (14) . Upon its translocation, C3G appears to activate the Rho family protein TC10, a member of the family of small GTP-binding proteins expressed in muscle and adipose tissue (15) . Upon overexpression in murine 3T3L1 adipocytes, insulin activates hTC10 in a CAP-dependent but PI 3-kinase-independent manner (14) . Although the physiologically relevant effectors that interact with TC10 are unknown, disruption of its activation blocks insulin-stimulated glucose transport and GLUT4 translocation. Moreover, the mistargeting of TC10 to a non-lipid raft domain by production of a TC10/K-Ras chimera or disruption of lipid raft microdomains via expression of a dominant-interfering mutant form of caveolin-3 also completely prevented the activation of TC10 by insulin (16) .
Although these experiments suggest that TC10 is a critical player in the hormonal regulation of glucose transport, they relied almost exclusively on the overexpression of the human form of TC10 in mouse cells. To study the endogenous forms of TC10 in the highly insulin-responsive mouse 3T3L1 cell line, we cloned the mouse ortholog of TC10. Interestingly, these efforts led to the identification of a closely related gene, referred to as TC10␤, and another variant termed TC10␤Long (TC10␤L). We describe here the characterization of this gene, the regulation of its gene product by insulin, and the evaluation of its role in glucose transport.
MATERIALS AND METHODS
Reagents-A mouse monoclonal anti-HA antibody and a rabbit polyclonal anti-C3G antibody were purchased from Santa Cruz Biotechnology. A polyclonal anti-caveolin antibody was purchased from BD Transduction Laboratories. GST-PAK1 PBD-agarose was purchased from Cytoskeleton, Inc. A mouse muscle Marathon RACE library was purchased from CLONTECH.
Expression Constructs-The coding sequence of mouse TC10␣ was PCR amplified from a mouse muscle cDNA library. The PCR product was cloned into the EcoRI site of a pKH3 vector driven by the cytomegalovirus (CMV) promoter (a gift from Dr. Ian Macara) that has sequences encoding for three HA epitope tags at the 5Ј-end of the cloning sites. To construct constitutively active (Q67L) and dominant negative (T23N) mutants of TC10␣, the wild type construct was mutated using the QuikChange site-directed mutagenesis kit (Stratagene). Comple-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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mentary primers on the site of mutagenesis for Q67L are 5Ј-GACA-CAGCTGGACTGGAAGACTATGATCGTCTGAG-3Ј and its complementary strand. For the T23N mutant the primers are 5Ј-GGGCGGTGGGCAAGAACTGCCTGCTCATGAGC-3Ј and its complementary strand.
The coding sequence of mouse TC10␤ was PCR amplified from a mouse 3T3L1 adipocyte cDNA library (17) . The PCR product was cloned into the BamHI/EcoRI site of pKH3. Point mutations (T25N and Q69L) in TC10␤ were also generated by site-directed mutagenesis. Complementary primers on the site of mutagenesis for Q69L are 5Ј-C-GACACTGCAGGACTGGATTACAACCAG-3Ј and its complementary strand. For the T25N mutant, the primers are 5Ј-CGCGGTGGGGAA-CTGCTTGCTGATGAG-3Ј and its complementary strand. The University of Michigan DNA sequencing core verified the authenticity of all mutants after mutagenesis.
Transfection of 3T3L1 Adipocytes-3T3L1 preadipocytes were cultured in Dulbecco's modified Eagle's medium containing 25 mM glucose and 10% calf serum at 37°C with 5% CO 2 . Confluent cultures were induced to differentiate into adipocytes as previously described (18) . Differentiated 3T3L1 adipocytes were transiently transfected as previously described (19) . Briefly, adipocytes suspended by mild trypsinization and electroporated with various amount of plasmid under low voltage conditions (160 V, 950 F). The cells were then allowed to adhere to tissue culture dishes for 40 h, and the adipocytes were serum starved for 3 h prior to incubation in the absence or presence of the hormone at 37°C. Cell activation was stopped by washing 3 times with cold phosphate-buffered saline and followed by the addition of lysis buffer (25 mM Tris, pH7.5, 5 mM MgCl 2 , 137 mM NaCl, 1% Nonidet P-40, 10% glycerol) containing 1 mM sodium orthovanadate and protease inhibitors. Lysates were then inverted at 4°C for 30 min and centrifuged at 13,000 rpm for 20 min.
Single Cell Microinjection-Differentiated 3T3L1 adipocytes were impaled using an Eppendorf model 5171 micromanipulator, and nuclei were injected with 50 g/ml of the appropriate cDNAs in 100 mM KCl, 5 mM Na 2 PO 4 , pH 7.2 with an Eppendorf model 5246 transinjector. The cells were allowed to recover for 24 h, fixed, and subjected to confocal fluorescent microscopy as described previously (12) .
Affinity Precipitation of TC10 Using GST-PAK1 PBD-This method was modified from Benard et al. (20) . Cell lysates in a volume of 100 l were incubated with 200 l of binding buffer (25 mM Tris, pH7.5, 1 mM DTT, 30 mM MgCl 2 , 40 mM NaCl, 0.5% Nonidet P-40) in the presence of 7 g of GST-PAK1 PBD-agarose (Cytoskeleton, Inc.) for 1 h at 4°C. The beads were washed three times with 25 mM Tris pH7.5, 1 mM DTT, 30 mM MgCl 2 , 40 mM NaCl, and 1% Nonidet P-40 and once with the same buffer without Nonidet P-40. The beads were suspended in 20 l Laemmli sample buffer. Proteins were separated by 4 -20% SDS-PAGE, transferred to a nitrocellulose membrane, and blotted with anti-HA monoclonal antibody (Santa Cruz Biotechnology.). Immunoblots were detected with chemiluminescence reagents from PerkinElmer Life Sciences.
Sucrose Gradient Centrifugation-3T3L1 adipocytes were electroporated with 50 g of HA-TC10␣ or ␤. Cells were then homogenized in HES buffer (20 mM Hepes, pH 7.5, 250 mM sucrose, 1 mM EDTA) containing protease inhibitors (Roche) with a Dounce homogenizer. Homogenized cells were centrifuged at low speed and the supernatant was centrifuged at 19,000 rpm to produce a crude plasma membrane fraction. The resulting pellet was resuspended in 1.5 ml of 40% sucrose/ MES buffer. This fraction was overlaid with 0.5 ml of 30, 20, 10, and 5% sucrose. The gradient was then centrifuged at 39,000 rpm for 16 h. 440-l fractions were collected from the top of each gradient. Aliquots of each fraction were immunoblotted with anti-caveolin and HA antibody.
Immunofluorescence Microscopy-3T3-L1 adipocytes were grown on 150-mm plates. Cells were electroporated with the appropriate HAtagged mouse TC10␣ and TC10␤ constructs. Cells were then plated onto coverslips that were placed in 6-well plates and allowed to recover for 4 -5 days. Cells were fixed and fluorescence was analyzed by confocal immunofluorescence microscopy as previously described (12) .
GST Fusion Protein Precipitation-GST-Rho
GTPase glutathione beads were incubated with buffer A (20 mM Tris, 1 mM DTT, 50 mM NaCl, 5% glycerol, 0.1% Nonidet P-40, 20 l/ml 0.5 M EDTA, and protease inhibitors) for 30 min at room temperature. Two aliquots were incubated with either buffer B (20 mM Tris, 1 mM DTT, 50 mM NaCl, 5% glycerol, 0.1% Nonidet P-40, 3 l/ml GDPϩ10 l/ml 1 M MgCl 2 , and protease inhibitors) or buffer C (20 mM Tris, 1 mM DTT, 50 mM NaCl, 5% glycerol, 0.1% Nonidet P-40, 3 l/ml GTP␥S ϩ10 l/ml 1 M MgCl 2 and protease inhibitors) for another hour at room temperature for GDP/GTP loading. GTPases were then incubated with lysates for 1 h at 4°C and washed intensively four times. Bound lysates were eluted from beads by boiling in loading buffer for 5 min.
GLUT4-EGFP Translocation Assays-Construction of all enhanced green fluorescence protein (EGFP) fusion proteins and translocation assays were done by the method of Thurmond et al. (21) . Briefly, 3T3L1 adipocytes were electroporated with 50 g of EGFP-tagged plasmid and 200 g of either empty vector or TC10 mutant constructs. Adipocytes were replated, allowed to recover overnight, and stimulated with or without 100 nM insulin for 30 min. The cells were then fixed, and EGFP fluorescence was analyzed by confocal immunofluorescence microscopy.
RESULTS
Cloning of Murine TC10 Genes-A mouse muscle RACE cDNA library was used to amplify a full-length cDNA encoding TC10. The first methionine was identified, although a stop codon was not found in the 180-bp 5Ј-untranslated region. The coding region was then amplified with mouse TC10-specific primers. The mouse TC10 gene contains an open reading frame of 205 amino acids that predicts a 23-kDa protein. The coding sequence of mouse TC10 is ϳ95% identical to the rat cDNA sequence (22) . However, the encoded protein sequence is completely identical to rat TC10 and exhibits only two amino acid changes (Val to Ile at 143 and Ile to Val at 172) from its human homolog (Fig. 1A) .
We performed an NCBI BLAST search to identify mouse EST sequences similar to the TC10 cDNA. Mouse ESTs were found that showed ϳ70% identity to the rat TC10 cDNA sequence (22) . PCR primers were designed to amplify the coding region of this mouse mRNA with the 3T3L1 adipocyte cDNA library. A full-length mRNA was cloned that encodes a 204-amino acid protein with 83% identity to TC10. After this analysis was completed, the cloning of TCL (TC10-like) was reported (23), which is a human ortholog of this mouse gene. Among the mouse ESTs, we identified other clones with sequences at the 5Ј-end different from the cDNA that was amplified. These clones contain a 10-amino acid extension of the coding sequence. Thus, we speculate that this TC10-like gene utilizes a different promoter or splicing process to generate two isoforms that vary at the amino terminus. A reverse transcription PCR confirmed that the longer form is also expressed in 3T3L1 adipocytes (data not shown).
The two mouse TC10 genes share identical sequences throughout the five Ras canonical boxes (G1-G5) as well as the effector domain. The main differences between the two genes are clustered in the amino-and carboxyl-terminal ends (Fig. 1B) . Despite these differences, they both have a unique CXXCCAAX box, a presumed signal for palmitoylation and prenylation. We refer to these two genes as TC10␣ and TC10␤ (Fig. 1B) .
Chromosomal Mapping of Mouse TC10␣-We performed a mouse-hamster radiation hybrid panel analysis to determine the chromosomal location of TC10␣ (ResGen). A human 180-kb bacterial artificial cosmid clone (GenBank TM accession no. AC018682) covering human TC10␣ was available in the GenBank TM . There are two clustered genes arranged tail-to-tail in this bacterial artificial cosmid clone. One gene represents TC10␣ and the other phosphatidylinositol glycan class F (PIGF). PIGF was mapped on human chromosome 2p16-21. The human TC10␣ gene contains five exons spanning 38 kb ( Fig. 2A) . Based on the human TC10 genomic organization, we designed a PCR forward primer in intron 1 (5Ј-GGGCAATTC-CTCTCCTACTTCT-3Ј) and a reverse primer (5Ј-GGGTCATC-TCGGAGATCAATCT-3Ј) in intron 2 to amplify the mousespecific genomic fragment by PCR for RH mapping. This primer set specifically amplified a 400-bp product using mouse 129 genomic DNA and no product using hamster A23 DNA as control. By analyzing 100 RH cell lines by PCR, mouse TC10␣ was localized on the distal end of chromosome 17, 20.09 cR from D17Mit129 (lod Ͼ3.0) (Fig. 2B) . These mapping results re-vealed that mouse TC10␣ is also close to the PIGF gene, suggesting that the genomic organization of this region is evolutionarily conserved.
Mouse TC10␣ and ␤ Expression and Localization in 3T3L1 Adipocytes-Because the primary event in the CAP/CrkII/C3G pathway appeared to be the translocation of these proteins to lipid rafts in response to insulin, we suspected that TC10, as the target of these proteins, might reside in this plasma membrane microdomain. Following the transfection of 3T3L1 adipocytes with HA-tagged TC10␣ or ␤, cells were fractionated by   FIG. 1. Cloning of mouse TC10 isoforms. A, the alignment of TC10␣ sequences between human, rat, and mouse is shown. Numbering refers to the published sequences. B, the alignment of mouse TC10␣ and ␤ and ␤ long forms with RhoA, Rac1, and cdc42. Mouse TC10 isoforms were aligned with mouse cdc42, Rac1, and RhoA using the ClustalW and Boxshade programs. G1-G5 indicate Ras canonical boxes. Conserved residues are in red. C, the mutagenesis of TC10 ␣ and ␤ and ␤ long form is shown. Red letters indicate the amino acids mutated for generating the dominant negative mutant (threonine to asparagine; T to N). Blue letters indicate the amino acid mutated for generating constitutively active mutants (glutamic acid to leucine; Q to L). Both mutants are marked with asterisks underneath. a continuous sucrose density gradient and immunoblotted with HA, flotillin, or caveolin antibodies. As shown in Fig. 3A , both TC10␣ and ␤ colocalized with caveolin-enriched fractions. To further confirm the localization of TC10␣ and ␤, we electroporated HA-tagged TC10 constructs and immunostained with anti-caveolin and anti-HA antibodies. The majority of TC10␣ and ␤ were co-immunostained with caveolin on the plasma membrane and were found in rosette structures at higher magnification on the lower section of the cells, as described previously for hTC10 (Fig. 3B) . Merging of the images revealed that every rosette structure identified by anti-caveolin staining exhibited staining for the two forms of TC10. These data are consistent with previous results demonstrating co-staining of the two forms of mTC10 with caveolin in rosette structures on plasma membrane sheets (16) , again indicating that the localization of endogenous TC10 is restricted to lipid raft microdomains in differentiated adipocytes.
Mouse TC10␣ and ␤ Are Activated in Response to InsulinThe detection of the two isoforms of TC10 in lipid rafts suggests that they might both be similarly activated by insulin. To examine whether mouse TC10␣ and ␤ can be activated in 3T3L1 adipocytes like human TC10␣, cells were electroporated with a cDNA encoding HA-mTC10␣ or ␤ or HA-hTC10␣ and then treated with insulin at different time points before harvest. Activation of the protein was detected by precipitation with immobilized PAK1, as described previously (14) . Interestingly, both mTC10␣ and ␤ were activated in response to insulin in 3T3L1 adipocytes over a time course similar to that observed with human TC10␣ (Fig. 4) . In all three cases, the activation was rapid and transient.
To determine whether the activation of mTC10 isoforms was 
FIG. 3. Subcellular localization of TC10␣ and ␤.
A, 3T3L1 adipocytes were electroporated with 50 g of HA-TC10␣ or ␤. Plasma membrane fractions of homogenized cells were resuspended in 1.5 ml of 40% sucrose/MES buffer. This fraction was overlaid with various concentrations of sucrose. The gradient was then centrifuged, and fractions were collected. Aliquots of each fraction were immunoblotted with anticaveolin and HA antibody. B, 3T3L1 adipocytes were electroporated with 400 g of HA-TC10␣ and ␤. Cells were plated on coverslips and recovered for 4 -5 days. Cells were then immunostained with anticaveolin and anti-HA antibodies as described under "Materials and Methods." downstream of the CAP/Cbl pathway, we coexpressed the HAtagged forms of the proteins with a mutant form of CAP. CAP⌬SH3 lacks the three SH3 domains and fails to interact with Cbl. Overexpression of this mutant blocks the translocation of Cbl to lipid raft microdomains (12) . Therefore, 3T3L1 adipocytes that were transfected with mTC10␣ or ␤ plus wild type CAP or the dominant-interfering CAP mutant (CAP⌬SH3) were assessed for TC10 activation (Fig. 5) . As expected, cotransfection with wild type CAP did not influence activation of either of the TC10 isoforms. However, activation of both forms of TC10 by insulin was inhibited by the overexpression of CAP⌬SH3, indicating that TC10␣ and ␤ are both downstream of the CAP/Cbl pathway.
TC10␣ but Not ␤ Blocks the Stimulation of Glucose Transport by Insulin-Our previous studies revealed that overexpression of wild type, dominant negative, and constitutively active mutants of human TC10␣ significantly inhibited insulin-stimulated glucose uptake and GLUT4 translocation in 3T3L1 adipocytes (14) . To investigate the function of mouse TC10␣, ␤, and ␤L, wild type, constitutively active (Q67L for TC10␣, Q69L for TC10␤ and Q79L for TC10␤L), and dominant negative (T23N for TC10␣, T25N for TC10␤, and T35N for TC10␤L) mutants were generated by site-directed mutagenesis (Fig.  1C) . 3T3L1 adipocytes were then cotransfected with the GLUT4-EGFP fusion proteins plus the various mTC10 cDNAs, and cells were treated with or without insulin. The representative confocal immunofluorescent images are presented for the dominant-interfering mutants in Fig. 6 . As established previously, insulin stimulated the translocation of an intracellular sequestered GLUT4-EGFP fusion protein to the plasma membrane, characterized by the appearance of a plasma membrane rim fluorescence (Fig. 6, panels a and e) . The expression of mTC10␣/T23N potently inhibited insulin-stimulated GLUT4-EGFP translocation (Fig. 6, panels b and f) . mTC10␤/T25N also prevented insulin-stimulated GLUT4-EGFP translocation, but was not nearly as effective as mTC10␣/T23N (Fig. 6, panels c  and g ). Furthermore, mTC10␤L/T35N had no significant effect on GLUT4-EGFP translocation (Fig. 6A, panels d and h) .
Quantitation of the effects of wild type, constitutively active, and dominant-interfering mutants of mTC10␣, mTC10␤ and mTC10␤/L on GLUT4 translocation is presented in Fig. 6B . Insulin stimulated the translocation of the fusion protein to the cell surface in ϳ75% of the transfected cells, whereas only 15% of the cells exhibited rim fluorescence in the basal state. Cotransfection with each of the three isoforms of mTC10␣ produced an 80% reduction in the number of cells responding to insulin. Cotransfection of the adipocytes with the corresponding forms of TC10␤ resulted in partial inhibition with ϳ50% of the cells displaying insulin-stimulated GLUT4-EGFP translocation. Although there was a very slight reduction in the extent of GLUT4 translocation in cells expressing mTC10␤L (ϳ65%), this was not statistically significant at the p Ͻ 0.01 level.
TC10␣ but Not ␤ Disrupts Adipocyte Cortical Actin-Several recent studies have reported that the cortical actin structures in muscle and adipocytes play essential roles in the insulinstimulated GLUT4 translocation process (24, 25) . In addition, the inhibition of insulin-stimulated GLUT4 translocation by the expression of human TC10␣ directly correlated with the disruption of adipocyte cortical actin (24) . Therefore, to examine the effect of murine TC10␣ and TC10␤ on adipocyte cortical actin, we next expressed these cDNAs as well as the hTC10␣ by single cell microinjection (Fig. 7) . As previously observed, phalloidin staining of filamentous actin demonstrated the presence of a thick cortical actin network lining the interior surface of the cells (Fig.  7, panels a and d) . Similar to that observed for human TC10␣ (24) , this cortical actin structure was dispersed in the cells expressing mTC10␣ (Fig. 7, panels b and c) . In contrast, the expression of mTC10␤ had no significant effect on the distribution of cortical actin (Fig. 7, panels d--f) . Counting the cells indicates that after overexpression of hTC10␣, 65% of the cells have cortical actin disruption compared with 69% for mTC10␣. In contrast, only 22% of the mTC10␤-expressing cells have disrupted cortical actin. Together, these data demonstrate that only the TC10 iso- forms that perturb adipocyte cortical actin are capable of inhibiting insulin-stimulated GLUT4 translocation.
DISCUSSION
The stimulation of glucose transport by insulin requires both phosphatidylinositol 3-kinase-dependent and -independent pathways (9, 19) . We recently described a novel signaling pathway that is segregated into a lipid raft subdomain of the plasma membrane. The insulin receptor catalyzes the tyrosine phosphorylation of the protooncogene Cbl, which is recruited to the receptor with the adaptor protein CAP (10, 11, 26) . Upon Cbl phosphorylation, the CAP/Cbl complex is translocated to lipid rafts via the interaction of the SoHo domain of CAP with the hydrophobic protein flotillin (12, 13) . Phospho-Cbl can in turn recruit the SH2/SH3 adapter protein CrkII to these microdomains along with the guanyl nucleotide exchange protein C3G. The insulin-stimulated recruitment of C3G to lipid rafts brings the exchange factor into proximity with the Rho family protein TC10, which appears to reside in lipid rafts because of its unique carboxyl-terminal sequences (14, 16) . TC10 undergoes activation via the C3G-catalyzed exchange of GTP for GDP, and the blockade of this pathway by overexpression of dominant negative forms of CAP prevents the stimulation of glucose transport by insulin (13, 14) .
A key determinant in the activation of TC10 by insulin lies in its localization in lipid raft microdomains. This property of the protein appears to be defined by its carboxyl terminal sequences. A TC10/K-Ras chimera was not activated by insulin FIG. 7 . Effect of mTC10␣ and ␤ on cortical actin. Differentiated 3T3L1 adipocytes were microinjected with expression plasmids encoding for HA epitope-tagged hTC10, mTC10␣, or mTC10␤ directly into the nucleus as described under "Materials and Methods". The cells were allowed to recover overnight, fixed, and subjected to confocal immunofluorescent microscopy for the HA epitope and F-actin (rhodaminelabeled phalloidin). These are representative images from three independent experiments in which individual cells were examined. and did not target to lipid rafts, whereas a TC10/H-ras chimera was insulin sensitive and localized into lipid rafts (16) . Interestingly, the second isoform of TC10 described here (TC10␤) is also activated by insulin treatment and is also localized in lipid rafts, providing further support for the functional importance of spatial targeting of this protein. Indeed, TC10␣ and ␤ are similarly activated by insulin in a CAP-dependent manner and localized in identical fractions by sucrose density gradients as well as by immunolocalization by confocal microscopy.
Despite similarities in function, the three isoforms of mTC10 differ in their impact on insulin-stimulated GLUT4 translocation. The overexpression of mTC10␣ profoundly inhibits GLUT4 translocation in response to insulin, as was observed for the human form of this protein. This inhibitory effect was produced with the wild type, constitutively active, and inactive forms of the protein. In contrast, TC10␤ only slightly inhibited insulin-stimulated GLUT4 translocation, whereas TC10␤L was essentially without effect. Although the underlying reasons for these differences in biological effect remain unknown, the ability to inhibit GLUT4 translocation appears to correlate with the disruption in cortical actin structure. This may also account for the surprising observation that overexpression of the wild type, constitutively active, and dominant-interfering mutants of the TC10␣ isoforms are all inhibitory. Furthermore, these findings suggest that there are important determinants of effector binding in the amino-terminal sequences, where the TC10 isoforms are the most divergent. Alternatively, the active form of the protein might prevent the interaction of endogenous TC10 with its effectors, perhaps targeting the protein to an incorrect location or dramatically changing the kinetics of the interaction. Indeed, preliminary results suggest that candidate effector molecules show different affinities for TC10␣ and ␤ in pull-down and immunoprecipitation experiments. In any case, TC10 isoforms appear to serve as signaling intermediates in the CAP/Cbl pathway, and the identification of multiple TC10 proteins in lipid raft microdomains will provide important clues toward understanding how TC10 isoforms mediate the effects of insulin on its target cells.
